Coronary microvascular dysfunction in stable ischaemic heart disease (non-obstructive coronary artery disease and obstructive coronary artery disease)
Udo Sechtem(University of Stuttgart), Novalia Sidik(University Hospitals Bristol NHS Foundation Trust), Hiroaki Shimokawa(Tohoku University), Shigeo Godo(Tohoku University), Gaetano Antonio Lanza(Agostino Gemelli University Polyclinic), David Brown(University of Iowa)
Cited by 68
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k